Valo Health - FDA Collaborative Study in Human Cardiac Tissu

Valo Health - FDA Collaborative Study in Human Cardiac Tissues Demonstrates Potential to Predict Clinical Efficacy of Cardiac Contractility Modulation Devices to Treat Heart Failure

/PRNewswire/ -- Valo Health, Inc ("Valo") shared the initial results of a collaborative study with the U.S. Food and Drug Administration (FDA), demonstrating...

Related Keywords

New York , United States , Boston , Massachusetts , San Francisco , California , Jennifer Hanley , Michaelp Graziano , Valo Biowire , Graeme Bell , Year Research Collaboration Between Valo , Drug Administration , Valo Health Inc , Valo Health , Findings Part , Five Year Research Collaboration Between Valo , Cardiac Contractility Modulation , Translational Biology , Opal Computational , Flagship Pioneering , Chief Communications , Chief Financial , Valo Health Llc ,